VetriScience Laboratories, Glyco Flex Stage 2, Canine Formula, 120 Soft Chews
UPC Code: 026664157218
Description
VetriScience® Laboratories’ GlycoFlex® 2 Bite-Sized Chews for Dogs represents the second stage in their comprehensive joint support life stages program for pets. It’s recommended for adult or maturing dogs, and dogs needing advanced joint support.
GlycoFlex 2 is veterinarian formulated.
With a higher quantity of glucosamine, and the inclusion of MSM, manganese, DMG and perna canaliculus, Glyco Flex 2 is formulated to support a lifetime of healthy joints and joint comfort. These bite-sized chews are available in a palatable, chicken liver flavor.
Packaging
120 Soft Chews
Suggested Use
Initial: (4 - 6 Weeks)
Up to 30 lbs: 1 soft chew daily.
31 - 60 lbs: 2 soft chews daily.
61 - 100 lbs: 4 soft chews daily.
101 lbs and over: 5 soft chews daily.
Maintenance: (After initial period)
Up to 30 lbs: 1 soft chew every other day.
31 - 60 lbs: 1 soft chew daily.
61 - 100 lbs: 2 soft chews daily.
101 lbs and over: 3 soft chews daily.
If giving more than 1 tablet/soft chew daily, divide between AM and PM.
About VetriScience Laboratories
For over 40 years, VetriScience has led the way in developing innovative supplement therapies to improve the lives of companion animals. They are committed to using extensively researched, pure ingredients to produce safe and highly effective products that make the lives of pets better. Their product catalog includes GlycoFlex and an extensive line of original formulas made by vets, for vets and manufactured in the USA. All their products are backed by a 100% Satisfaction Guarantee.
Safety
Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.
Disclaimer
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.